CEL-SCI Corporation Reports Third Quarter Fiscal 2023 Financ

CEL-SCI Corporation today reported financial results for the quarter ended June 30, 2023, as well as key clinical and corporate developments.


Clinical and Corporate Developments this quarter...

Related Keywords

Baltimore , Maryland , United States , Virginia , Vienna , Wien , Austria , Canada , American , Geert Kersten , Health Canada , European Society For Radiotherapy , Securities Exchange , Drug Administration , Neck Cancer Society , International Conference On Head , Exchange Commission , Corporate Developments , American Head , Annual International Conference , Neck Cancer , Leukocyte Interleukin Injection , European Society , Leukocyte Interleukin , Orphan Drug , Securities Act , Securities Exchange Act ,